#Biotech #IPOs Sizzle Amid R&D Successes - WSJ http://t.co/M3gFjHRUK2 cc @GHABAULT @ALarigaudrieBFM
July 02, 2013
Publicité
/http%3A%2F%2Fs2.wsj.net%2Fimg%2Fwsj_select_p_377x107.gif)
Biotech IPOs Sizzle Amid R&D Successes
Biotechnology companies are enjoying their best run with initial public offerings in a decade, amid an upswing in new drug approvals, strong performance by some already public biotech firms and legal changes that make it easier for companies to gauge investor.